ARTL   $1.13  -1.74% Market Closed After Close 1.13 0.0

Artelo Biosciences Inc
Total Cash 5.60M
totalCashPerShare 1.736
EBITDA
Total Debt 120.00K
quickRatio 5.96
currentRatio 6.562
Total Revenue
debtToEquity 1.644
Revenue/Share
ROA -0.54333997
ROE -0.88581
grossProfits
freeCashflow -5.61M
operatingCashflow -9.40M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -1.45M
forwardPE -1.3863636
floatShares 3.20M
sharesOutstanding 3.23M
sharesShort 27.24K
sharesShortPriorMonth 36.26K
dateShortInterest
sharesPercentSharesOut 0.01%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.01%
Short Ratio help_outline 4.05%
shortPercentOfFloat 0.01%
impliedSharesOutstanding
bookValue 2.261
Price To Book help_outline 0.54
earningsQuarterlyGrowth
netIncomeToCommon -10.44M
trailingEps -3.35%
forwardEps -0.88%
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.46 3Q 2024
institutionsCount 6
lastUpdated Nov. 7, 2024, 2:38 a.m.